rs878854355
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_ModeratePP5_Moderate
The NM_001017980.4(VMA21):c.*6A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 23)
Consequence
VMA21
NM_001017980.4 3_prime_UTR
NM_001017980.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.439
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PM2
?
Very rare variant in population databases, with high coverage;
PP3
?
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
PP5
?
Variant X-151405064-A-G is Pathogenic according to our data. Variant chrX-151405064-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 208803.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chrX-151405064-A-G is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VMA21 | NM_001017980.4 | c.*6A>G | 3_prime_UTR_variant | 3/3 | ENST00000330374.7 | ||
VMA21 | NM_001363810.1 | c.*6A>G | 3_prime_UTR_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VMA21 | ENST00000330374.7 | c.*6A>G | 3_prime_UTR_variant | 3/3 | 1 | NM_001017980.4 | P1 | ||
VMA21 | ENST00000370361.5 | c.*6A>G | 3_prime_UTR_variant | 4/4 | 5 | ||||
VMA21 | ENST00000477649.1 | n.392A>G | non_coding_transcript_exon_variant | 3/3 | 3 |
Frequencies
GnomAD3 genomes ? Cov.: 23
GnomAD3 genomes
?
Cov.:
23
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome ? Cov.: 23
GnomAD4 genome
?
Cov.:
23
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
X-linked myopathy with excessive autophagy Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Mar 08, 2023 | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on VMA21 function (PMID: 23315026). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 208803). This variant has been observed in individuals with X-linked myopathy with excessive autophagy (XMEA) (PMID: 23315026). This variant is not present in population databases (gnomAD no frequency). This variant occurs in a non-coding region of the VMA21 gene. It does not change the encoded amino acid sequence of the VMA21 protein. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 2013 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
Cadd
Uncertain
Dann
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: -5
Find out detailed SpliceAI scores and Pangolin per-transcript scores at